This occurs by stimulating increased expression of indoleamine 2,3-dioxygenase (IDO) and interleukin-10 (IL-10), among other anti-inflammatory mediators, promoting a tumor microenvironment conducive to cancer survival [48,49]. The gene discussed is IL10; the disease is neoplasm.